COMPASS THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $19.4M | $43.5M | $24.2M | $30.4M | $19.3M | $27.0M | $34.9M | $16.5M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $153.5M | $158.6M | $153.9M | $166.6M | $175.3M | $183.6M | $194.8M | $122.6M |
| Property, Plant & Equipment | $592.0K | $744.0K | $898.0K | $1.1M | $1.2M | $1.4M | $1.6M | $1.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $155.6M | $161.1M | $156.9M | $170.0M | $179.2M | $188.0M | $199.6M | $127.8M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $854.0K | $4.1M | $2.3M | $724.0K | $1.1M | $3.4M | $2.8M |
| Total Current Liabilities | $9.5M | $3.9M | $7.8M | $9.1M | $9.7M | $11.2M | $16.2M | $9.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $9.5M | $4.1M | $8.3M | $10.0M | $10.9M | $12.7M | $18.0M | $11.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-339.2M | $-326.1M | $-315.3M | $-301.9M | $-291.9M | $-280.7M | $-272.8M | $-261.2M |
| Total Stockholders' Equity | $146.1M | $157.1M | $148.5M | $160.0M | $168.3M | $175.3M | $181.6M | $116.1M |